बिसोप्रोलोल और हाइड्रोक्लोरोथायज़ाइड और पियोग्लिटाज़ोन और ग्लिमेपिराइड का इंटरैक्शन

Beta-blockers may further increase the risk of severe hypoglycemia when used concurrently with sulfonylureas.

The concomitant use of beta-blockers with sulfonylureas may increase the risk of severe hypoglycemia (see WARNINGS – Hypoglycemia ).

Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required.

…glycemic control: danazol, glucagon, somatropin, protease inhibitors, atypical antipsychotic medications (e.g., olanzapine and clozapine), barbiturates, diazoxide, laxatives, rifampin, thiazides and other diuretics, corticosteroids, phenothiazines, thyroid hormones, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics (e.g., epinephrine, albuterol,…

The signs of hypoglycemia may be reduced or absent in patients taking sympatholytic drugs such as beta-blockers, clonidine, guanethidine, and reserpine.

Beta-blockers, clonidine, and reserpine may lead to either potentiation or weakening of pioglitazone and glimepiride tablets glucose-lowering effect.